Market Place
Sourcing Support
Students Week at Tiefenbacher Group – Connecting Global Talents!
17 Dec 2025 //
PRESS RELEASE
Tiefenbacher Group at CPHI Frankfurt 2025
24 Oct 2025 //
PRESS RELEASE
Celebrating the Spirit of Diwali at Tiefenbacher Laboratories
20 Oct 2025 //
PRESS RELEASE
Tiefenbacher Group and Neuraxpharm announce the launch of Riulvy
10 Oct 2025 //
PRESS RELEASE
Tiefenbacher Group Career Stories No 3
29 Aug 2025 //
PRESS RELEASE
Tiefenbacher Group celebrates World Humanitarian Day
20 Aug 2025 //
PRESS RELEASE
Tiefenbacher Group Career Stories No 2
15 Aug 2025 //
PRESS RELEASE
Tiefenbacher Group Career Stories No 1
05 Aug 2025 //
PRESS RELEASE
Tiefenbacher New Market Launch: Buprenorphine Patches in SA
01 Aug 2025 //
PRESS RELEASE
Tiefenbacher Group Self-Care Day
25 Jul 2025 //
PRESS RELEASE
Pioneering Healthcare at Tiefenbacher Group
23 Jul 2025 //
PRESS RELEASE
Tiefenbacher Group about affordable medicines
10 Jul 2025 //
PRESS RELEASE
Tiefenbacher Group International Social Day
01 Jul 2025 //
PRESS RELEASE
Tiefenbacher Laboratories Supporting Women’s Health
28 May 2025 //
PRESS RELEASE
Tiefenbacher Group celebrates World Health Day
07 Apr 2025 //
PRESS RELEASE
Tiefenbacher Group celebrating new buildings in Hyderabad
25 Mar 2025 //
PRESS RELEASE
Tiefenbacher, OnDosis & Star celebrate iF Design Award for OYSTA
10 Mar 2025 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals Launch: Varenicline in UK
05 Feb 2025 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals New Market Launch: Amifampridine
30 Jan 2025 //
PRESS RELEASE
Tiefenbacher Group and Pharmacists Without Borders
21 Nov 2024 //
PRESS RELEASE
Pioneering Healthcare at Tiefenbacher Group
02 Oct 2024 //
PRESS RELEASE
Tiefenbacher Pharma New Market Launch Ezetimibe/Atorvastatin
18 Sep 2024 //
PRESS RELEASE
Tiefenbacher Group Earns EcoVadis Silver Medal!
09 Sep 2024 //
PRESS RELEASE
Tiefenbacher PharmaFirst to Market Launch Varenicline in Europe
22 Aug 2024 //
PRESS RELEASE
Tiefenbacher Group partnering with Pharmacists Without Borders
01 Aug 2024 //
PRESS RELEASE
Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis
08 May 2024 //
PRESS RELEASE
Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate
08 Apr 2024 //
PRESS RELEASE
Tiefenbacher Group awarded the EcoVadis Silver Medal!
19 Mar 2024 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals Launch Of Generic Teriflunomide
27 Sep 2023 //
PRESS RELEASE
Successful Approval of manufacturing and laboratory facilities by Saudi Food and Drug Authority
10 May 2023 //
PRESS RELEASE
Tiefenbacher Pharma Successfully Launches The Antihistamine Bilastine
14 Mar 2023 //
PRESS RELEASE
Tiefenbacher Manufacturing Sites Have Been Successfully Registered By The UAE
25 Feb 2023 //
PRESS RELEASE
Tiefenbacher Successfully Launches Generic Version Of The Psoriasis Apremilast
01 Dec 2022 //
PRESS RELEASE
Four Drugs Recommended For Approval By Chmp At April Meeting
25 Apr 2022 //
MEDWATCH
Tiefenbacher API + Ingredients Secures The Supply Of Controlled Substances For Customers And Patients
22 Jun 2021 //
PRESS RELEASE
Tiefenbacher API + Ingredients Offers Pitavastatine Calcium For Novel Therapies
11 May 2021 //
PRESS RELEASE
Tiefenbacher API + Ingredients Starts To Offer The First Api Based On Green Chemistry
15 Apr 2021 //
PRESS RELEASE
What Trends Driving The Adalimumab Biosimilar Market? Global Key Players
19 May 2020 //
OPENPR
What Driving Adalimumab Biosimilar Market? Top Players Alfred E. Tiefenbacher,
09 Mar 2020 //
OPENPR
Global Fampridine Market Research Strategies and Forecasts, 2020 to 2025
08 Mar 2020 //
BCCOURIER
